Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An announcement from Rigel ( (RIGL) ) is now available.
Dr. Brian Kotzin has decided to step down from his role as an independent director on Rigel Pharmaceuticals’ Board of Directors, as well as from all board committees he serves on, effective September 16, 2024. His resignation is amicable and not due to any disputes concerning Rigel’s operational, policy, or practice matters.
Find detailed analytics on RIGL stock on TipRanks’ Stock Analysis page.
